Repository logo
 

Early-life stress and inflammation: A systematic review of a key experimental approach in rodents.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Pama, EA Claudia 
Lynall, Mary-Ellen 
Khan, Shahid 
Clatworthy, Menna R 

Abstract

Repeated maternal separation is the most widely used pre-clinical approach to investigate the relationship between early-life chronic stress and its neuropsychiatric and physical consequences. In this systematic review, we identified 46 studies that conducted repeated maternal separation or single-episode maternal separation and reported measurements of interleukin-1b, interleukin-6, interleukin-10, tumour necrosis factor-alpha, or microglia activation and density. We report that in the short-term and in the context of later-life stress, repeated maternal separation has pro-inflammatory immune consequences in diverse tissues. Repeated maternal separation animals exhibit greater microglial activation and elevated pro-inflammatory cytokine signalling in key brain regions implicated in human psychiatric disorders. Notably, repeated maternal separation generally has no long-term effect on cytokine expression in any tissue in the absence of later-life stress. These observations suggest that the elevated inflammatory signalling that has been reported in humans with a history of early-life stress may be the joint consequence of ongoing stressor exposure together with potentiated neural and/or immune responsiveness to stressors. Finally, our findings provide detailed guidance for future studies interrogating the causal roles of early-life stress and inflammation in disorders such as major depression.

Description

Keywords

Maternal separation, chronic stress, cytokines, depression, early-life adversity, immune system, neuroimmune responsiveness

Journal Title

Brain Neurosci Adv

Conference Name

Journal ISSN

2398-2128
2398-2128

Volume Title

4

Publisher

SAGE Publications

Rights

All rights reserved
Sponsorship
Medical Research Council (MC_G0802534)
Medical Research Council (MR/L014815/1)
Arthritis Research UK (21777)
Wellcome Trust (093875/Z/10/Z)
Medical Research Council (G1000183)
Medical Research Council (MR/N024907/1)
MRC (MR/S006257/1)
MRC The authors of this article are funded in part by a GlaxoSmithKline Varsity Award with core funding from the Medical Research Council (G1000183) and Wellcome Trust (093875/Z/10/Z) in support of the Behavioural and Clinical Neuroscience Institute at Cambridge University. EGD acknowledges funding from the Gates Cambridge Trust. ML is supported by a fellowship from the Medical Research Council (MR/S006257/1). MRC received support from the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre, the NIHR Blood and Transplant Research Unit, a Medical Research Council New Investigator Research Grant (MR/N024907/1), an Arthritis Research UK Cure Challenge Research Grant (#21777), and an NIHR Research Professorship (RP-2017-08-ST2-002). ETB is supported by an NIHR Senior Investigator Award.